comparemela.com

Latest Breaking News On - Commercializing - Page 15 : comparemela.com

Novavax Nuvaxovid COVID-19 Vaccine Authorized in the United Kingdom for Use as a Booster in Adults

Novavax, Inc. , a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare. | November 10, 2022

New zealandUnited kingdomSouth africaErika schultzStanleyc erckEuropean commissionRegulatory agencyExchange commissionAdministration of nuvaxovidEuropean unionSerum institute of indiaNovavax incApple appChief executive officerSafety informationVaccine efficacy novavax trial

Awakn Life Sciences Secures Financing to Expand Nordic Commercial Operations

TORONTO - Awakn Life Sciences Corp. , a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use. | October 26, 2022

United statesAnthony tennysonAwakn life sciences corpLife sciencesAlcohol use disorderAwakn osloLowan stewartRegional directorLoan agreementUnited states securities actNews publishingAwakn life sciences corp stock exchangePress releaseLcohol awkn ca05455w1086

Vera Therapeutics to Present Final Phase 2 Results of MAU868 in Kidney Transplant Recipients with Reactivated BK Virus Infection and New Analysis of Phase 2a JANUS Trial of Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2022 Annual Meeting

BRISBANE, Calif., Oct. 17, 2022 Vera Therapeutics, Inc. , a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious. | October 17, 2022

United statesOrange county convention centerLos angelesJoyce allaireJonathan barrattUniversity of leicesterAmplyx pharmaceuticals incSinai medical centerVera therapeutics incExchange commissionPfizer incAmerican society of nephrology kidney weekAmerican societyNephrology kidney weekRandomized phaseKidney transplant

Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System

Axonics, Inc. , a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the first patient. | September 9, 2022

United statesKaren noblettGaryj grayUniversity of albertaKipnes urology centreAxonics incHealth canadaDepartment of surgeryDeloitte technology fastNorth americaTechnology fastNc stock exchangePress releaseIrst axnx us05465p1012

Supernus to Present at the 2022 Wells Fargo Healthcare Conference

ROCKVILLE, Md., Aug. 31, 2022 Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system . | August 31, 2022

United statesJack khattarJacka khattarTimothyc decPeter vozzoExchange commissionSecurities exchangeSupernus pharmaceuticals incSupernus pharmaceuticalsWells fargoFargo healthcare conferenceEncore boston harborInvestor relationsPrivate securities litigation reform actSecurities exchange actSenior vice president

vimarsana © 2020. All Rights Reserved.